Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis

Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis

Marieke Krol,1 Gert de Voer,2 Ulrike Osowski3 1QuintilesIMS, Capelle aan den Ijssel, the Netherlands; 2Merck B.V., Schiphol-Rijk, the Netherlands; 3Merck KGaA, Darmstadt, Germany Purpose: Long-term treatment adherence among patients with multiple sclerosis (MS) is a general concern, with an establ...

Full description

Bibliographic Details
Main Authors: Krol M, de Voer G, Osowski U
Format: Article
Language:English
Published: Dove Medical Press 2017-07-01
Series:Patient Preference and Adherence
Subjects:
multiple sclerosis
injection device
interferon beta-1a
observational study
Online Access:https://www.dovepress.com/patient-adherence-to-subcutaneous-ifn-beta-1a-injections-using-the-reb-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/patient-adherence-to-subcutaneous-ifn-beta-1a-injections-using-the-reb-peer-reviewed-article-PPA

Similar Items